Inadequate Clinical Response to Sirukumab, an Anti-IL-6 Monoclonal Antibody, Can be Predicted after a Single Dose of Treatment in Patients with Rheumatoid Arthritis

被引：0

作者：

Daga, Shruti ^{[1
]}

Aletaha, Daniel ^{[2
]}

Hsu, Benjamin ^{[3
]}

Gilbride, Jennifer ^{[4
]}

Christie, Jacquie ^{[5
]}

Loza, Matthew ^{[3
]}

Dasgupta, Bidisha ^{[3
]}

Campbell, Kim ^{[3
]}

Brown, Kurt ^{[6
]}

Rao, Ravi ^{[5
]}

Tak, Paul P. ^{[5
]}

机构：

[1] GlaxoSmithKline, Uxbridge, Middx, England

[2] Med Univ Vienna, Div Rheumatol, Dept Med 3, Vienna, Austria

[3] Janssen Res & Dev LLC, Spring House, PA USA

[4] Sum Sq Ltd, Walkern, Herts, England

[5] GlaxoSmithKline, Stevenage, Herts, England

[6] GlaxoSmithKline, Collegeville, PA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1478

引用

页数：3